Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

The Most Important Question About Radiotherapy in Prostate Cancer Has Been Answered

The Most Important Question About Radiotherapy in Prostate Cancer Has Been Answered

Prostate cancer patients may avoid postoperative radiotherapy according to RADICALS-RT results presented by Parker and colleagues at the European Society for Medical Oncology (ESMO) Congress 2019. The study addresses prostate cancer surgery and whether subsequent radiotherapy has benefits outweighing side effects, a long-standing question.

RADICALS-RT is a clinical trial, the largest postoperative radiotherapy study in prostate cancer to date. Between men routinely receiving radiotherapy shortly after surgery and those receiving it when cancer recurred, at 5 years there was no difference in disease recurrence rate between groups.

RADICALS-RT Clinical Trial

The study enrolled men undergoing prostate cancer surgery in England, Denmark, Canada and Ireland, totaling 1.396 patients. They were randomized to postoperative radiotherapy or standard observation (active follow-up), keeping radiotherapy as an option if disease recurred.

  • With median follow-up of 5 years, progression-free survival was 85% in the radiotherapy group and 88% with standard care.
  •  At year 1 after surgery, incontinence rates were 5,3% with radiotherapy and 2,7% with standard care, a statistically significant difference.
  • Longer follow-up is needed for overall and distant metastasis-free survival data.

Results from another study, the ARTISTIC meta-analysis, confirmed RADICALS findings favoring observation over early postoperative radiotherapy.

The findings show radiotherapy is equally effective regardless of whether given shortly after surgery or later for recurrent disease. Strong evidence now supports observation as the standard postoperative approach, reserving radiotherapy for recurrence.

The good news is that many men will avoid radiotherapy side effects, including urine leakage and urinary tract narrowing that may make urination difficult. Both may occur after surgery alone, but radiotherapy increases the risk.

The ARTISTIC meta-analysis, combining 3 studies and 2.151 patients, found that adjuvant radiotherapy had no evidence of improving event-free survival compared with salvage radiotherapy after recurrence.

These are the first results suggesting postoperative prostate cancer radiotherapy may be omitted or delayed in some patients. This will shorten treatment and improve resource use, since modern radiotherapy is technically complex and expensive. Close follow-up will, however, be necessary to identify patients requiring salvage radiotherapy.

Sources

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

The Most Important Question About Radiotherapy in Prostate Cancer Has Been Answered

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy